BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21105870)

  • 21. Community context and healthcare quality: the impact of community resources on licensing and accreditation of substance abuse treatment agencies.
    Archibald ME; Rankin CP
    J Behav Health Serv Res; 2013 Oct; 40(4):442-56. PubMed ID: 23666273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perceptions of the state policy environment and adoption of medications in the treatment of substance use disorders.
    Knudsen HK; Abraham AJ
    Psychiatr Serv; 2012 Jan; 63(1):19-25. PubMed ID: 22227755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uninsurance among children whose parents are losing Medicaid coverage: Results from a statewide survey of Oregon families.
    DeVoe JE; Krois L; Edlund T; Smith J; Carlson NE
    Health Serv Res; 2008 Feb; 43(1 Pt 2):401-18. PubMed ID: 18199193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns in Geographic Distribution of Substance Use Disorder Treatment Facilities in the US and Accepted Forms of Payment From 2010 to 2021.
    Cantor JH; DeYoreo M; Hanson R; Kofner A; Kravitz D; Salas A; Stein BD; Kapinos KA
    JAMA Netw Open; 2022 Nov; 5(11):e2241128. PubMed ID: 36367729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of ownership on access in outpatient substance abuse treatment.
    Nahra TA; Alexander J; Pollack H
    J Subst Abuse Treat; 2009 Jun; 36(4):355-65. PubMed ID: 19339142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicaid coverage in substance use disorder treatment after the affordable care act.
    Andrews CM; Pollack HA; Abraham AJ; Grogan CM; Bersamira CS; D'Aunno T; Friedmann PD
    J Subst Abuse Treat; 2019 Jul; 102():1-7. PubMed ID: 31202283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Michigan's substance abuse services: readiness for managed care.
    Stauffer M
    Behav Healthc Tomorrow; 1995; 4(4):57-8. PubMed ID: 10172404
    [No Abstract]   [Full Text] [Related]  

  • 28. Health services for women in outpatient substance abuse treatment.
    Campbell CI; Alexander JA
    Health Serv Res; 2005 Jun; 40(3):781-810. PubMed ID: 15960691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organizational determinants of outpatient substance abuse treatment duration in women.
    Campbell CI; Alexander JA; Lemak CH
    J Subst Abuse Treat; 2009 Jul; 37(1):64-72. PubMed ID: 19038526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women-Centered Drug Treatment Services and Need in the United States, 2002-2009.
    Terplan M; Longinaker N; Appel L
    Am J Public Health; 2015 Nov; 105(11):e50-4. PubMed ID: 26378825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.
    Abraham AJ; Knudsen HK; Rieckmann T; Roman PM
    J Stud Alcohol Drugs; 2013 Mar; 74(2):258-65. PubMed ID: 23384373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking cessation services and smoke-free policies at substance abuse treatment facilities: national survey results.
    Shi Y; Cummins SE
    Psychiatr Serv; 2015 Jun; 66(6):610-6. PubMed ID: 25686819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decline In Public Substance Use Disorder Treatment Centers Most Serious In Counties With High Shares Of Black Residents.
    Cummings JR; Wen H; Ko M
    Health Aff (Millwood); 2016 Jun; 35(6):1036-44. PubMed ID: 27269020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organizing Publicly Funded Substance Use Disorder Treatment in the United States: Moving Toward a Service System Approach.
    Padwa H; Urada D; Gauthier P; Rieckmann T; Hurley B; Crèvecouer-MacPhail D; Rawson RA
    J Subst Abuse Treat; 2016 Oct; 69():9-18. PubMed ID: 27568505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The availability of LGBT-specific mental health and substance abuse treatment in the United States.
    Williams ND; Fish JN
    Health Serv Res; 2020 Dec; 55(6):932-943. PubMed ID: 32970327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facility-level, state, and financial factors associated with changes in the provision of smoking cessation services in US substance abuse treatment facilities: Results from the National Survey of Substance Abuse Treatment Services 2006 to 2012.
    Cohn A; Elmasry H; Niaura R
    J Subst Abuse Treat; 2017 Jun; 77():107-114. PubMed ID: 28476262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in spending for substance abuse treatment, 1986-2003.
    Mark TL; Levit KR; Vandivort-Warren R; Coffey RM; Buck JA;
    Health Aff (Millwood); 2007; 26(4):1118-28. PubMed ID: 17630455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tennessee's failed managed care program for mental health and substance abuse services.
    Chang CF; Kiser LJ; Bailey JE; Martins M; Gibson WC; Schaberg KA; Mirvis DM; Applegate WB
    JAMA; 1998 Mar; 279(11):864-9. PubMed ID: 9516002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
    Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
    Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparities in access to substance abuse treatment among people with intellectual disabilities and serious mental illness.
    Slayter EM
    Health Soc Work; 2010 Feb; 35(1):49-59. PubMed ID: 20218453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.